Curia supports greener peptide future!
Peptide-based pharmaceuticals have been growing in popularity in recent years, but synthesizing these complex drugs presents expensive environmental challenges. Pioneering collaboration between Curia, formerly, AMRI, and the world-leading Peptide Science Laboratory Institution, in South Africa, has shown that the green coupling reagent propylphosphonic anhydride (T3P) is useful for solid phase peptide synthesis (SPPS). Curia can provide technical support regarding T3P and can also offer its CDMO technologies. Curia is the manufacturer of T3P, a green, safe and highly efficient condensation reagent. Due to its patented manufacturing process only Curia can offer T3P in a superior quality.
The potential impact of Curia’s work for both the environment and for business is significant. Ultimately, the routine use of T3P in SPPS could lead to the greener, more cost-effective production of peptides, thus enabling scientific discovery and accelerating medical advances. Request a meeting with us to learn more about how T3P can enable greener, cost-effective peptide synthesis.
